I-Mab Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
AKRO
Akero Therapeutics, Inc. |
$28.56 | $1.59 B | -7.1 | 60 | $0 |
APLS
Apellis Pharmaceuticals, Inc. |
$33.32 | $4.90 B | -11.77 | 702 | $396.59 M |
ASND
Ascendis Pharma A/S |
$138.79 | $7.77 B | -14.19 | 879 | $266.72 M |
BGNE
BeiGene, Ltd. |
$181.62 | $17.07 B | -20.76 | 10600 | $2.46 B |
BPMC
Blueprint Medicines Corporation |
$90.46 | $6.47 B | -21.48 | 638 | $249.38 M |
CGEM
Cullinan Oncology, Inc. |
$12.27 | $1.29 B | -7.16 | 85 | $0 |
DSGN
Design Therapeutics, Inc. |
$6.35 | $217.51 M | -3.7 | 54 | $0 |
ERAS
Erasca, Inc. |
$2.57 | $647.94 M | -2.83 | 126 | $0 |
FHTX
Foghorn Therapeutics Inc. |
$5.02 | $332.53 M | -2.73 | 116 | $34.16 M |
GLUE
Monte Rosa Therapeutics, Inc. |
$7.05 | $243.38 M | -1.59 | 133 | $0 |
GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
IMVT
Immunovant, Inc. |
$26.08 | $3.68 B | -13.39 | 207 | $0 |
KRYS
Krystal Biotech, Inc. |
$158.52 | $4.70 B | 75.42 | 229 | $50.70 M |
KYMR
Kymera Therapeutics, Inc. |
$40.82 | $2.02 B | -13.13 | 184 | $78.59 M |
LYEL
Lyell Immunopharma, Inc. |
$0.61 | $619.50 M | -2.7 | 224 | $130,000 |
MRTX
Mirati Therapeutics, Inc. |
$58.70 | $4.12 B | -4.82 | 587 | $12.44 M |
NRIX
Nurix Therapeutics, Inc. |
$19.57 | $930.10 M | -5.89 | 284 | $76.99 M |
RVMD
Revolution Medicines, Inc. |
$44.39 | $6.66 B | -10.51 | 490 | $11.58 M |
STTK
Shattuck Labs, Inc. |
$1.11 | $333.81 M | -3.64 | 75 | $1.66 M |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |